PDC and acute myeloid leukemia: The activation of pDCs may be a viable therapeutic approach to increase the efficacy of AML treatment, by promoting the selective death of tumor cells and potentially improving clinical outcomes in patients. In addition, the combination of pDC activation with chemotherapeutic agents showed a synergistic effect, increasing treatment efficacy and suggesting that pDC [29]